Biotechnology professional with 25+ years of proven track record as a product development scientist with expertise in formulation development, sterile product development of various biotechnology products, clinical and commercial product development, technology transfer and technology evaluation. Twenty years of experience as a process development or product quality team leader for AMG 114, denosumab (Prolia and XGEVA), evolocumab (Repatha Sureclick® and Pushtronex™), axicabtagene ciloleucel (Yescarta®), brexucabtagene autoleucel (Tecartus®), tabelecleucel (tab-cel®), and ATA188 which exemplifies a thorough knowledge of protein and cell biochemistry, strong proficiency with pharmaceutical product commercialization and life cycle management with the ability to recognize strategic implications of complex product development activities and manage them cross-functionally. Demonstrates command in handling complexity and ambiguity; ability to generate, process and communicate information through relevant business analyses to influence decision-making. Fifteen years of supervisory experience demonstrating the ability to recruit, train, and motivate staff by integrating management principles into the daily work environment. Possesses superior verbal skills to communicate vertically and horizontally through multiple channels, leverage contact network to motivate diverse teams, and enable cross-functional collaboration.